Lynx1 Capital Management LP - 26 Dec 2025 SCHEDULE 13D/A Report for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP)

Filing Manager
Lynx1 Capital Management LP
Reporting Manager
Lynx1 Capital Management LP
Security
Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share
Symbol
NEUP
Shares outstanding
5,370,110 shares
Disclosed Ownership
875,328 shares
Ownership
16%
Form type
SCHEDULE 13D/A
Filing time
29 Dec 2025, 16:33:14 UTC
Date of event
26 Dec 2025
Previous filing
02 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Lynx1 Capital Management LP disclosed 16% ownership in Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP) on 26 Dec 2025."

Quick Takeaways

  • Lynx1 Capital Management LP filed SCHEDULE 13D/A for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP).
  • Disclosed ownership: 16%.
  • Date of event: 26 Dec 2025.

What Changed

  • Previous schedule filing date: 02 Dec 2025.
  • Current filing was accepted on 29 Dec 2025, 16:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lynx1 Capital Management LP 16% 875,328 0 875,328 /s/ Weston Nichols By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member 0001910456
Weston Nichols 16% 875,328 0 875,328 /s/ Weston Nichols Weston Nichols, individually

Sponsored